Marianna Almeida Hollaender
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marianna Almeida Hollaender has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Yamada Fujimura Júnior
Division of Medicine, Marilia medical school, São Paulo, Brazil
1 shared publication - Amanda Souza Do Nascimento
Universidade Estadual de Londrina, Londrina, PR, Brazil
1 shared publication - Bela Parekh
University of Michigan Medical School, Ann Arbor, MI, USA
1 shared publication - Dillan Cunha Amaral
Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
1 shared publication - Giovana de Souza Gaio
Universidade da Região de Joinville, UNIVILLE, Joinville, SC, Brazil
1 shared publication - Jaime Guedes
Ophthalmology, Glaucoma Research Center, Wills Eye Hospital, Philadelphia, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by GN1 Sistemas e Publicacoes Ltd. in Arquivos Brasileiros de Oftalmologia
- Vol. 88 (6) , 1-8
Perioperative subconjunctival steroid injection in dropless cataract surgery: a systematic review and meta-analysis
The advantages and disadvantages of using perioperative subconjunctival steroid injections in dropless cataract surgery continue to be debated. A systematic review of PubMed, EMBASE, and the Cochrane Central database identified five studies-two randomized controlled trials and three non-randomized studies-encompassing 70,751 eyes. Among these, 12,319 eyes (17.4%) received subconjunctival steroid injections, while 58,432 eyes (82.6%) were managed with topical steroids. The Cochrane Collaboration's RoB 2 tool was applied for bias assessments in randomized controlled trials, and heterogeneity was assessed using the I² statistics. No statistically significant differences were found between the two groups regarding macular edema (p=0.249), visual acuity (p=0.73), or laser flare count (p=0.45). Both subconjunctival injections and topical steroids demonstrated comparable efficacy and safety in controlling postoperative inflammation after cataract surgery. Additional research is warranted to validate these conclusions.
- 1 January 2025
- Published by GN1 Sistemas e Publicacoes Ltd. in Arquivos Brasileiros de Oftalmologia
- Vol. 88 (6) , 1-8
Open AccessPerioperative subconjunctival steroid injection in dropless cataract surgery: a systematic review and meta-analysis
The advantages and disadvantages of using perioperative subconjunctival steroid injections in dropless cataract surgery continue to be debated. A systematic review of PubMed, EMBASE, and the Cochrane Central database identified five studies-two randomized controlled trials and three non-randomized studies-encompassing 70,751 eyes. Among these, 12,319 eyes (17.4%) received subconjunctival steroid injections, while 58,432 eyes (82.6%) were managed with topical steroids. The Cochrane Collaboration's RoB 2 tool was applied for bias assessments in randomized controlled trials, and heterogeneity was assessed using the I² statistics. No statistically significant differences were found between the two groups regarding macular edema (p=0.249), visual acuity (p=0.73), or laser flare count (p=0.45). Both subconjunctival injections and topical steroids demonstrated comparable efficacy and safety in controlling postoperative inflammation after cataract surgery. Additional research is warranted to validate these conclusions.